AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / LIFE INSURANCE
Pharming Group N.V. ADS, each representing 10 ordinary shares
XNAS · usd
SIC 6719 · LIFE INSURANCE
FIGI BBG00YN70W58
11.20▲ 0.53 (4.97%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
10.67
Day's Range
10.76 – 11.45
52-Week Range
9.11 – 22.01
Volume
25.8K
Avg Volume
26.9K
Share Statistics
Shares Outstanding
Employees
409
Exchange
XNAS
Listed
2020-12-23
Share count as of December 31, 2025

Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR)
What is Pharming Group N.V. ADS, each representing 10 ordinary shares's Market Cap?
Pharming Group N.V. ADS, each representing 10 ordinary shares's Market Cap is $7.9B, based on as-reported figures from SEC (XBRL) filings.
What is Pharming Group N.V. ADS, each representing 10 ordinary shares's Enterprise Value?
Pharming Group N.V. ADS, each representing 10 ordinary shares's Enterprise Value is $7.7B, based on as-reported figures from SEC (XBRL) filings.
What is Pharming Group N.V. ADS, each representing 10 ordinary shares's Trailing P/E?
Pharming Group N.V. ADS, each representing 10 ordinary shares's Trailing P/E is 3096.5×, based on as-reported figures from SEC (XBRL) filings.
What is Pharming Group N.V. ADS, each representing 10 ordinary shares's Price / Sales?
Pharming Group N.V. ADS, each representing 10 ordinary shares's Price / Sales is 20.9×, based on as-reported figures from SEC (XBRL) filings.
What is Pharming Group N.V. ADS, each representing 10 ordinary shares's EV / Revenue?
Pharming Group N.V. ADS, each representing 10 ordinary shares's EV / Revenue is 20.5×, based on as-reported figures from SEC (XBRL) filings.
What is Pharming Group N.V. ADS, each representing 10 ordinary shares's EV / EBITDA?
Pharming Group N.V. ADS, each representing 10 ordinary shares's EV / EBITDA is 283.1×, based on as-reported figures from SEC (XBRL) filings.
What is Pharming Group N.V. ADS, each representing 10 ordinary shares's Revenue (TTM)?
Pharming Group N.V. ADS, each representing 10 ordinary shares's Revenue (TTM) is $376.1M, based on as-reported figures from SEC (XBRL) filings.
What is Pharming Group N.V. ADS, each representing 10 ordinary shares's Net Income (TTM)?
Pharming Group N.V. ADS, each representing 10 ordinary shares's Net Income (TTM) is $2.5M, based on as-reported figures from SEC (XBRL) filings.
What is Pharming Group N.V. ADS, each representing 10 ordinary shares's EBITDA?
Pharming Group N.V. ADS, each representing 10 ordinary shares's EBITDA is $27.2M, based on as-reported figures from SEC (XBRL) filings.
What is Pharming Group N.V. ADS, each representing 10 ordinary shares's Diluted EPS (TTM)?
Pharming Group N.V. ADS, each representing 10 ordinary shares's Diluted EPS (TTM) is 0.00, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · PHARAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Profit or loss [abstract]
Revenues
Costs of sales
Gross profit
Other income
Research and development
General and administrative
Marketing and sales
Other Operating Costs
Operating profit / (loss)
Fair value gain (loss) on revaluation
Other finance income
Other finance expenses
Finance (cost) / gain, net
Share of net profits / (loss) in associates using the equity method
Profit / (loss) before tax
Income tax (expense) / credit
Profit / (loss) for the year
Attributable to:
Equity holders of the parent
Non-controlling interests
Basic (loss) / earnings per share (in usd per share)
Diluted (loss) / earnings per share (in usd per share)